Endocarditis caused by Rhodotorula successfully treated with 5-fluorocytosine

Br Heart J. 1975 Jan;37(1):101-4. doi: 10.1136/hrt.37.1.101.

Abstract

A 7-year-old boy suffering from aortic regurgitation and mitral stenosis and regurgitation was admitted with endocarditis caused by Rhodotorula pilimanae and was treated successfully with orally administered antifungal agent, namely 5-fluorocytosine (5-FC). A dose of 100 mg per kg body weight, divided into four equal parts, was prescribed. After a prolonged febrile period his temperature dropped to normal on the fourth day of 5-FC therapy. Review of the published reports disclosed few cases of endocarditis due to Rhodotorula spp. and this case seems to be the first treated with 5-FC. Follow-up in one year, after discharge from the hospital, revealed no evidence of relapse.

MeSH terms

  • Administration, Oral
  • Antifungal Agents / therapeutic use
  • Aortic Valve Insufficiency / complications
  • Candidiasis / drug therapy*
  • Child
  • Cytosine / administration & dosage
  • Cytosine / analogs & derivatives*
  • Endocarditis / complications
  • Endocarditis / drug therapy*
  • Flucytosine / therapeutic use*
  • Humans
  • Leukocyte Count
  • Male
  • Mitosporic Fungi / pathogenicity
  • Mitral Valve Insufficiency / complications
  • Mitral Valve Stenosis / complications

Substances

  • Antifungal Agents
  • Cytosine
  • Flucytosine